Add to ORKGIntroduction: the need for biomarkers in prostate cancer Prostate cancer is one of the most common epi-thelial tumour types and the second leading cause of cancer death in men in the USA [Jemal et al
Objectives: This report summarises major new findings in the field of prostate cancer (PCa) presente...
Urologic cancers are an umbrella term for cancers of the prostate, kidney, bladder, penis, and testi...
Over the last decade, the improvement in molecular techniques and the acquisition of genomic informa...
Contains fulltext : 177633.pdf (publisher's version ) (Open Access)INTRODUCTION: M...
Prostate cancer is the most prevalent non-skin cancer in men and is the leading cause of cancer-rela...
Contains fulltext : 58214.pdf (publisher's version ) (Closed access)Early diagnosi...
Although a rapidly growing number of candidate biological markers of prognosis and/or response to sp...
Discriminating patients with a low risk of progression from those with lethal prostate cancer is one...
<div><p>Prostate cancer (PCa) is fifth leading cause of cancer-associated deaths in men worldwide. A...
Purpose: Localised prostate cancer diagnosis and management is increasingly complex due to its heter...
The main diagnostic biomarker in current use is prostate-specific antigen (PSA) and it is one of the...
Background:. Research of biomarkers in genitourinary tumors goes along with the development of compl...
Prostate cancer is an enigmatic disease. Although prostatic-intraepithelial neoplasia appears as ear...
The existing clinical biomarkers for prostate cancer (PCa) are not ideal, since they cannot specific...
Background: Research of biomarkers in genitourinary tumors goes along with the development of comple...
Objectives: This report summarises major new findings in the field of prostate cancer (PCa) presente...
Urologic cancers are an umbrella term for cancers of the prostate, kidney, bladder, penis, and testi...
Over the last decade, the improvement in molecular techniques and the acquisition of genomic informa...
Contains fulltext : 177633.pdf (publisher's version ) (Open Access)INTRODUCTION: M...
Prostate cancer is the most prevalent non-skin cancer in men and is the leading cause of cancer-rela...
Contains fulltext : 58214.pdf (publisher's version ) (Closed access)Early diagnosi...
Although a rapidly growing number of candidate biological markers of prognosis and/or response to sp...
Discriminating patients with a low risk of progression from those with lethal prostate cancer is one...
<div><p>Prostate cancer (PCa) is fifth leading cause of cancer-associated deaths in men worldwide. A...
Purpose: Localised prostate cancer diagnosis and management is increasingly complex due to its heter...
The main diagnostic biomarker in current use is prostate-specific antigen (PSA) and it is one of the...
Background:. Research of biomarkers in genitourinary tumors goes along with the development of compl...
Prostate cancer is an enigmatic disease. Although prostatic-intraepithelial neoplasia appears as ear...
The existing clinical biomarkers for prostate cancer (PCa) are not ideal, since they cannot specific...
Background: Research of biomarkers in genitourinary tumors goes along with the development of comple...
Objectives: This report summarises major new findings in the field of prostate cancer (PCa) presente...
Urologic cancers are an umbrella term for cancers of the prostate, kidney, bladder, penis, and testi...
Over the last decade, the improvement in molecular techniques and the acquisition of genomic informa...